Miniature Dosimeters Autonomously Monitor EMR Exposure
|
By MedImaging International staff writers Posted on 16 Jan 2020 |

Image: A prototype autonomous EMR dosimeter (Photo courtesy of NU)
A millimeter-scale, ultra-low-power wireless digital platform provides continuous electromagnetic radiation (EMR) dosimetry for time-managed, wireless consumer devices.
Developed at Northwestern University (NU; Evanston, IL, USA) and the Korea Advanced Institute of Science and Technology (KAIST; Daejeon, Republic of Korea), the miniaturized digital dosimeter provides continuous EMR monitoring in an autonomous mode at one or multiple wavelengths simultaneously, transmitting the data over long-range wireless protocols to standard consumer devices. A single button cell battery powers the unit over a multiyear life span, enabled by the combined use of a light-powered, accumulation mode of detection and a light-adaptive, ultralow-power circuit design.
The dosimeter includes an accumulation detection module (ADM) for dosimetry and a Bluetooth low energy (BLE) system on a chip for wireless communication. A key feature is that the built-in ADM can directly measure continuous dose exposure without power consumption. As a result, it remains in an ultra-low sleep mode in the absence of light while continuously monitoring dosage via the ADM. When the dose exceeded a threshold, the device briefly wakes up to wirelessly transmit exposure data using BLE protocols to a smartphone, and resets the ADM and quickly return to sleep mode.
The ADM also includes a photodiode, supercapacitor, and a metal oxide semiconductor field-effect transistor (MOSFET). The miniaturized forms of the device have already been tested on sunglass clips, earrings, and wristbands for personalized EMR exposure detection. Field studies have shown that the dosimeter is extremely efficient in monitoring short-wavelength blue light from indoor lighting and display systems, as well as ultraviolet (UV), visible, and infrared (IR) radiation from the sun. The study was published on December 13, 2109, in Science Advances.
“The key feature of the ADM is that it directly measures exposure dose in a continuous fashion, without any power consumption. By contrast, conventional digital approaches approximate dose through computational time integration across a series of brief measurements of intensity, each performed using active, battery-powered electronics,” concluded lead author Kyeongha Kwon, PhD, of NU and KAIST, and colleagues. “Lack of interface ports and mechanical switches and the absence of need for battery replacement allow hermetic sealing of device for waterproof, sweat-resistant, and wear-resistant capabilities.”
Overexposure or underexposure to EMR can accumulate with latent consequences; where excessive exposure to UV and blue light from the sun or emissions of tanning beds and cellphones, can have associated health risks. For instance, repetitive keratinocyte damage from chronic exposure to UV is fundamental to cause skin cancer. The shorter wavelengths of the visible spectrum can generate reactive oxygen species (ROS) in the skin to cause DNA damage, hyperpigmentation and inflammation, alongside collagen and elastin degradation. Blue light can cause photochemical damage in retinal tissue to accelerate age-related maculopathy and modulate retinal control of the human circadian rhythm to suppress melatonin secretion.
Related Links:
Northwestern University
Korea Advanced Institute of Science and Technology
Developed at Northwestern University (NU; Evanston, IL, USA) and the Korea Advanced Institute of Science and Technology (KAIST; Daejeon, Republic of Korea), the miniaturized digital dosimeter provides continuous EMR monitoring in an autonomous mode at one or multiple wavelengths simultaneously, transmitting the data over long-range wireless protocols to standard consumer devices. A single button cell battery powers the unit over a multiyear life span, enabled by the combined use of a light-powered, accumulation mode of detection and a light-adaptive, ultralow-power circuit design.
The dosimeter includes an accumulation detection module (ADM) for dosimetry and a Bluetooth low energy (BLE) system on a chip for wireless communication. A key feature is that the built-in ADM can directly measure continuous dose exposure without power consumption. As a result, it remains in an ultra-low sleep mode in the absence of light while continuously monitoring dosage via the ADM. When the dose exceeded a threshold, the device briefly wakes up to wirelessly transmit exposure data using BLE protocols to a smartphone, and resets the ADM and quickly return to sleep mode.
The ADM also includes a photodiode, supercapacitor, and a metal oxide semiconductor field-effect transistor (MOSFET). The miniaturized forms of the device have already been tested on sunglass clips, earrings, and wristbands for personalized EMR exposure detection. Field studies have shown that the dosimeter is extremely efficient in monitoring short-wavelength blue light from indoor lighting and display systems, as well as ultraviolet (UV), visible, and infrared (IR) radiation from the sun. The study was published on December 13, 2109, in Science Advances.
“The key feature of the ADM is that it directly measures exposure dose in a continuous fashion, without any power consumption. By contrast, conventional digital approaches approximate dose through computational time integration across a series of brief measurements of intensity, each performed using active, battery-powered electronics,” concluded lead author Kyeongha Kwon, PhD, of NU and KAIST, and colleagues. “Lack of interface ports and mechanical switches and the absence of need for battery replacement allow hermetic sealing of device for waterproof, sweat-resistant, and wear-resistant capabilities.”
Overexposure or underexposure to EMR can accumulate with latent consequences; where excessive exposure to UV and blue light from the sun or emissions of tanning beds and cellphones, can have associated health risks. For instance, repetitive keratinocyte damage from chronic exposure to UV is fundamental to cause skin cancer. The shorter wavelengths of the visible spectrum can generate reactive oxygen species (ROS) in the skin to cause DNA damage, hyperpigmentation and inflammation, alongside collagen and elastin degradation. Blue light can cause photochemical damage in retinal tissue to accelerate age-related maculopathy and modulate retinal control of the human circadian rhythm to suppress melatonin secretion.
Related Links:
Northwestern University
Korea Advanced Institute of Science and Technology
Latest Radiography News
- AI Detection Tool Improves Identification of Lobular Breast Cancer
- New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
- AI Boosts Breast Cancer Detection and Cuts Screening Workload
- AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
- Routine Mammograms Could Predict Future Cardiovascular Disease in Women
- AI Detects Early Signs of Aging from Chest X-Rays
- X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
- AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
- AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
- AI Hybrid Strategy Improves Mammogram Interpretation
- AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
- RSNA AI Challenge Models Can Independently Interpret Mammograms
- New Technique Combines X-Ray Imaging and Radar for Safer Cancer Diagnosis
- New AI Tool Helps Doctors Read Chest X‑Rays Better
- Wearable X-Ray Imaging Detecting Fabric to Provide On-The-Go Diagnostic Scanning
- AI Helps Radiologists Spot More Lesions in Mammograms
Channels
MRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read more
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
Routine Cardiac CT Enhanced to Predict Heart Failure Risk
Heart failure, a progressive inability of the heart to pump blood effectively, often develops silently before symptoms appear. Clinicians need reliable ways to detect myocardial injury early and stratify... Read more
New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
Breast evaluation often requires correlating findings from mammography, digital breast tomosynthesis, MRI, ultrasound, and newer volumetric techniques. Switching between separate viewers to track changes... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







